The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs
Open accessAbstract
BACKGROUND: Several short antimicrobial peptides that are rich in tryptophan and arginine residues were designed with a series of simple modifications such as end capping and cyclization. The two sets of hexapeptides are based on the Trp- and Arg-rich primary sequences from the "antimicrobial centre" of bovine lactoferricin as well as an antimicrobial sequence obtained through the screening of a hexapeptide combinatorial library. METHODOLOGY/PRINCIPAL FINDINGS: HPLC, mass spectrometry and antimicrobial assays were carried out to explore the consequences of the modifications on the serum stability and microbicidal activity of the peptides. The results show that C-terminal amidation increases the antimicrobial activity but that it makes little difference to its proteolytic degradation in human serum. On the other hand, N-terminal acetylation decreases the peptide activities but significantly increases their protease resistance. Peptide cyclization of the hexameric peptides was found to be highly effective for both serum stability and antimicrobial activity. However the two cyclization strategies employed have different effects, with disulfide cyclization resulting in more active peptides while backbone cyclization results in more proteolytically stable peptides. However, the benefit of backbone cyclization did not extend to longer 11-mer peptides derived from the same region of lactoferricin. Mass spectrometry data support the serum stability assay results and allowed us to determine preferred proteolysis sites in the peptides. Furthermore, isothermal titration calorimetry experiments showed that the peptides all had weak interactions with albumin, the most abundant protein in human serum. CONCLUSIONS/SIGNIFICANCE: Taken together, the results provide insight into the behavior of the peptides in human serum and will therefore aid in advancing antimicrobial peptide design towards systemic applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Antimicrobial Peptides (AMPs): Peptide Structure and Mode of Action
Park, Y.-K., & Hahm, K. (2005) · BMB Reports · doi:10.5483/bmbrep.2005.38.5.507 · Cited by 121
RetractedAntimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Calculation of protein extinction coefficients from amino acid sequence data
Gill, S. C., & von Hippel, P. H. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90602-7 · Cited by 5,283
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,080
Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action
Chan, D. I., Prenner, E. J., & Vogel, H. J. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.04.006 · Cited by 1,039
Self-citationPark, C. B., Kim, H. S., & Kim, S. C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8159 · Cited by 896
Magainins as paradigm for the mode of action of pore forming polypeptides
Matsuzaki, K. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(98)00014-8 · Cited by 589
Gifford, J. L., Hunter, H. N., & Vogel, H. J. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5373-z · Cited by 528
Self-citationHigh-throughput generation of small antibacterial peptides with improved activity
Hilpert, K., Volkmer-Engert, R., Walter, T., & Hancock, R. E. W. (2005) · Nature Biotechnology · doi:10.1038/nbt1113 · Cited by 375
Impact of LL-37 on anti-infective immunity
Bowdish, D. M. E., Davidson, D. J., Lau, Y. E., Lee, K., Scott, M. G., & Hancock, R. E. W. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0704380 · Cited by 374
Krijgsveld, J., Zaat, S. A. J., Meeldijk, J., van Veelen, P. A., Fang, G., Poolman, B., Brandt, E., Ehlert, J. E., Kuijpers, A. J., Engbers, G. H. M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.27.20374 · Cited by 338
Self-citationRaguse, T. L., Porter, E. A., Weisblum, B., & Gellman, S. H. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0270423 · Cited by 283
Rosengren, K. J., Clark, R. J., Daly, N. L., Göransson, U., Jones, A., & Craik, D. J. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0367703 · Cited by 270
Effects of pH and salinity on the antimicrobial properties of clavanins
Lee, I. H., Cho, Y., & Lehrer, R. I. (1997) · Infection and Immunity · doi:10.1128/iai.65.7.2898-2903.1997 · Cited by 254
Salt-Resistant Alpha-Helical Cationic Antimicrobial Peptides
Friedrich, C., Scott, M. G., Karunaratne, N., Yan, H., & Hancock, R. E. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1542 · Cited by 219
Structure-Based Design of an Indolicidin Peptide Analogue with Increased Protease Stability,
Rozek, A., Powers, J.-P. S., Friedrich, C. L., & Hancock, R. E. W. (2003) · Biochemistry · doi:10.1021/bi035643g · Cited by 206
Dathe, M., Nikolenko, H., Klose, J., & Bienert, M. (2004) · Biochemistry · doi:10.1021/bi035948v · Cited by 186
Powell, M. F., Stewart, T., Jr Otvos, L., Urge, L., Gaeta, F. C. A., Sette, A., Arrhenius, T., Thomson, D., Soda, K., & Colon, S. M. (1993) · Pharmaceutical Research · doi:10.1023/a:1018953309913 · Cited by 182
A review: The active peptide of lactoferrin
TOMITA, M., TAKASE, M., BELLAMY, W., & SHIMAMURA, S. (1994) · Pediatrics International · doi:10.1111/j.1442-200x.1994.tb03250.x · Cited by 180
Antimicrobial activity of short arginine‐ and tryptophan‐rich peptides
Strøm, M. B., Rekdal, Ø., & Svendsen, J. S. (2002) · Journal of Peptide Science · doi:10.1002/psc.398 · Cited by 175
Ziconotide: an update and review
Williams, J. A., Day, M., & Heavner, J. E. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.9.1575 · Cited by 173
Antibacterial activity in bovine lactoferrin-derived peptides
Hoek, K. S., Milne, J. M., Grieve, P. A., Dionysius, D. A., & Smith, R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.54 · Cited by 170
Synthetic Antimicrobial Peptidomimetics with Therapeutic Potential
Haug, B. E., Stensen, W., Kalaaji, M., Rekdal, Ø., & Svendsen, J. S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701600a · Cited by 160
Svenson, J., Brandsdal, B. O., Stensen, W., & Svendsen, J. S. M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0703542 · Cited by 154
Helix Stability Confers Salt Resistance upon Helical Antimicrobial Peptides
Park, I. Y., Cho, J. H., Kim, K. S., Kim, Y.-B., Kim, M. S., & Kim, S. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311418200 · Cited by 145
Cyclization Strategies in Peptide Derived Drug Design
Li, P., & Roller, P. P. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023394209 · Cited by 124
Schibli, D. J., Hwang, P. M., & Vogel, H. J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00214-8 · Cited by 116
Self-citationDevelopment of novel antibacterial peptides that kill resistant isolates
Čudić, M., Condie, B. A., Weiner, D. J., Lysenko, E. S., Xiang, Z., O‐Sullivan, I., Bulet, P., & Ötvös, L. (2002) · Peptides · doi:10.1016/s0196-9781(02)00244-9 · Cited by 102
Schibli, D. J., Nguyen, L. T., Kernaghan, S. D., Rekdal, Ø., & Vogel, H. J. (2006) · Biophysical Journal · doi:10.1529/biophysj.106.085837 · Cited by 95
Self-citationJing, W., Hunter, H. N., Hagel, J., & Vogel, H. J. (2003) · Journal of Peptide Research · doi:10.1034/j.1399-3011.2003.00050.x · Cited by 93
Self-citationThe interactions of antimicrobial peptides derived from lysozyme with model membrane systems
Hunter, H. N., Jing, W., Schibli, D. J., Trinh, T., Park, I. Y., Kim, S. C., & Vogel, H. J. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.12.004 · Cited by 91
Self-citationAntimicrobial peptides in the interactions between insects and flagellate parasites
Boulanger, N., Bulet, P., & Lowenberger, C. A. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.04.003 · Cited by 87
Unger, T., Ziv, O., & Shai, Y. (2001) · Biochemistry · doi:10.1021/bi0026066 · Cited by 86
Lai, J. R., Huck, B. R., Weisblum, B., & Gellman, S. H. (2002) · Biochemistry · doi:10.1021/bi026127d · Cited by 78
Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin
Nguyen, L. T., Schibli, D. J., & Vogel, H. J. (2004) · Journal of Peptide Science · doi:10.1002/psc.629 · Cited by 78
Self-citationAlternative stabilities of a proline‐rich antibacterial peptide in vitro and in vivo
Noto, P. B., Abbadessa, G., Cassone, M., Mateo, G. D., Agelan, A., Wade, J. D., Szabó, D., Kocsis, B., Nagy, K., Rozgonyi, F., et al. (2008) · Protein Science · doi:10.1110/ps.034330.108 · Cited by 70
Intracellular delivery of bovine lactoferricin’s antimicrobial core (RRWQWR) kills T-leukemia cells
Richardson, A. M., de Antueno, R., Duncan, R., & Hoskin, D. W. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.083 · Cited by 67
Structural Consequences of Carboxyamidation of Dermaseptin S3
Shalev, D. E., Mor, A., & Kustanovich, I. M. (2002) · Biochemistry · doi:10.1021/bi016013m · Cited by 63
Daptomycin: A cyclic lipopeptide antimicrobial agent
Jeu, L., & Fung, H. B. (2004) · Clinical Therapeutics · doi:10.1016/j.clinthera.2004.11.014 · Cited by 61
Tam, J. P., Lu, Y., & Yang, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208429200 · Cited by 59
The interaction of arginine‐ and tryptophan‐rich cyclic hexapeptides with Escherichia coli membranes
Junkes, C., Wessolowski, A., Farnaud, S., Evans, R. W., Good, L., Bienert, M., & Dathe, M. (2007) · Journal of Peptide Science · doi:10.1002/psc.940 · Cited by 45
Appelt, C., Wessolowski, A., Söderhäll, J. A., Dathe, M., & Schmieder, P. (2005) · ChemBioChem · doi:10.1002/cbic.200500095 · Cited by 44
Antimicrobial Peptides in Oral Cancer
Meyer, J. E., & Harder, J. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207782110372 · Cited by 30
Rosengren, K. J., Göransson, U., Ötvös, L., & Craik, D. J. (2004) · Biopolymers · doi:10.1002/bip.20159 · Cited by 21
Structure-Based Design of Potent Histatin Analogues
Brewer, D., & Lajoie, G. (2002) · Biochemistry · doi:10.1021/bi015926d · Cited by 21
Antimicrobial Effect of Halocidin-Derived Peptide in a Mouse Model ofListeriaInfection
Jang, W. S., Lee, S., Lee, Y. S., Shin, Y. P., Shin, K. H., Sung, B.-H., Kim, B. S., Lee, S. H., & Lee, I. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00635-07 · Cited by 16
Cited by
The expanding scope of antimicrobial peptide structures and their modes of action
Nguyen, L. T., Haney, E. F., & Vogel, H. J. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.05.001 · Cited by 1,604
Self-citationKumar, P., Kizhakkedathu, J., & Straus, S. (2018) · Biomolecules · doi:10.3390/biom8010004 · Cited by 1,227
Antimicrobial peptides: mechanism of action, activity and clinical potential
Zhang, Q.-Y., Yan, Z.-B., Meng, Y.-M., Hong, X.-Y., Shao, G., Ma, J.-J., Cheng, X.-R., Liu, J., Kang, J., & Fu, C.-Y. (2021) · Military Medical Research · doi:10.1186/s40779-021-00343-2 · Cited by 1,065
Multifaceted Roles of Disulfide Bonds. Peptides as Therapeutics
Góngora-Benítez, M., Tulla-Puche, J., & Albericio, F. (2014) · Chemical Reviews · doi:10.1021/cr400031z · Cited by 655
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
Chen, C. H., & Lu, T. K. (2020) · Antibiotics · doi:10.3390/antibiotics9010024 · Cited by 598
Metadata
- Authors
- Nguyen, L. T., Chau, J. K., Perry, N. A., de Boer, L., Zaat, S. A. J., & Vogel, H. J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-09-10
- Volume
- 5
- Issue
- 9
- Pages
- e12684
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2038283518
- Cited by
- 333
- References
- 47
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.